Log in

NASDAQ:ACIUAC Immune News Headlines

$7.51
-0.07 (-0.92 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$7.12
Now: $7.51
$7.97
50-Day Range
$4.24
MA: $6.71
$8.65
52-Week Range
$4.07
Now: $7.51
$10.14
Volume128,907 shs
Average Volume176,088 shs
Market Capitalization$507.38 million
P/E Ratio11.73
Dividend YieldN/A
Beta0.54

Headlines

AC Immune (NASDAQ ACIU) News Headlines

Source:
DateHeadline
Newsflash: AC Immune SA (NASDAQ:ACIU) Analysts Have Been Trimming Their Revenue ForecastsNewsflash: AC Immune SA (NASDAQ:ACIU) Analysts Have Been Trimming Their Revenue Forecasts
finance.yahoo.com - April 4 at 5:07 PM
SVB Leerink Comments on AC Immune SAs Q1 2020 Earnings (NASDAQ:ACIU)SVB Leerink Comments on AC Immune SA's Q1 2020 Earnings (NASDAQ:ACIU)
www.americanbankingnews.com - April 3 at 7:17 AM
AC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative DiseasesAC Immune Presents the Latest Preclinical Data on Novel Drug Targets for Neurodegenerative Diseases
finance.yahoo.com - April 2 at 4:57 PM
AC Immune (NASDAQ:ACIU) Releases Quarterly  Earnings Results, Misses Estimates By $0.06 EPSAC Immune (NASDAQ:ACIU) Releases Quarterly Earnings Results, Misses Estimates By $0.06 EPS
www.americanbankingnews.com - March 31 at 7:50 AM
AC Immune EPS misses by CHF0.03, misses on revenueAC Immune EPS misses by CHF0.03, misses on revenue
seekingalpha.com - March 30 at 8:20 PM
AC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D OutlookAC Immune Reports Full-Year 2019 Financial Results and Provides 2020 R&D Outlook
finance.yahoo.com - March 30 at 7:09 AM
 Analysts Anticipate AC Immune SA (NASDAQ:ACIU) Will Announce Quarterly Sales of $3.57 Million Analysts Anticipate AC Immune SA (NASDAQ:ACIU) Will Announce Quarterly Sales of $3.57 Million
www.americanbankingnews.com - March 27 at 5:20 AM
 Analysts Expect AC Immune SA (NASDAQ:ACIU) Will Announce Earnings of -$0.22 Per Share Analysts Expect AC Immune SA (NASDAQ:ACIU) Will Announce Earnings of -$0.22 Per Share
www.americanbankingnews.com - March 25 at 3:14 AM
AC Immune earns second Morphomer Tau milestone from LillyAC Immune earns second Morphomer Tau milestone from Lilly
seekingalpha.com - March 23 at 1:56 PM
Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immunes Clinical Advisory BoardInternationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune's Clinical Advisory Board
www.marketwatch.com - March 20 at 8:16 AM
Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory BoardInternationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory Board
finance.yahoo.com - March 20 at 8:16 AM
Moderna (MRNA) Catches Eye: Stock Jumps 6.4%Moderna (MRNA) Catches Eye: Stock Jumps 6.4%
finance.yahoo.com - March 18 at 1:06 PM
Head to Head Comparison: Takeda Pharmaceutical (OTCMKTS:TKPYY) versus AC Immune (OTCMKTS:ACIU)Head to Head Comparison: Takeda Pharmaceutical (OTCMKTS:TKPYY) versus AC Immune (OTCMKTS:ACIU)
www.americanbankingnews.com - March 18 at 9:00 AM
AC Immune SA (NASDAQ:ACIU) Short Interest Up 18.0% in FebruaryAC Immune SA (NASDAQ:ACIU) Short Interest Up 18.0% in February
www.americanbankingnews.com - March 13 at 4:00 AM
Four presentations at AAT-AD/PD™ focus meetingFour presentations at AAT-AD/PD™ focus meeting
www.globenewswire.com - March 5 at 11:38 AM
AC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus MeetingAC Immune to Present New Data Demonstrating the Depth of its Neurodegenerative Programs at the Upcoming Advances in Alzheimer’s and Parkinson’s Therapies Focus Meeting
finance.yahoo.com - March 5 at 11:38 AM
Is AC Immune SA's (NASDAQ:ACIU) CEO Pay Justified?Is AC Immune SA's (NASDAQ:ACIU) CEO Pay Justified?
finance.yahoo.com - February 24 at 8:04 AM
AC Immune SA (NASDAQ:ACIU) Has A ROE Of 17%AC Immune SA (NASDAQ:ACIU) Has A ROE Of 17%
finance.yahoo.com - December 24 at 8:50 AM
Did Hedge Funds Drop The Ball On AC Immune SA (ACIU) ?Did Hedge Funds Drop The Ball On AC Immune SA (ACIU) ?
finance.yahoo.com - December 16 at 5:39 PM
AC Immune to Present at Jefferies 2019 London Healthcare ConferenceAC Immune to Present at Jefferies 2019 London Healthcare Conference
finance.yahoo.com - November 14 at 9:03 AM
AC Immune Q3 2019 Financial Results and Business UpdateAC Immune Q3 2019 Financial Results and Business Update
finance.yahoo.com - November 13 at 7:57 AM
AC Immune Hosts Key Opinion Leader Event: Untangling Tau Pathology to Treat Alzheimers and Neurodegenerative DiseasesAC Immune Hosts Key Opinion Leader Event: 'Untangling' Tau Pathology to Treat Alzheimer's and Neurodegenerative Diseases
www.marketwatch.com - November 6 at 7:01 PM
Were Hedge Funds Right About Souring On AC Immune SA (ACIU)?Were Hedge Funds Right About Souring On AC Immune SA (ACIU)?
finance.yahoo.com - November 6 at 7:01 PM
AC Immune Hosts Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative DiseasesAC Immune Hosts Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases
finance.yahoo.com - November 6 at 7:01 PM
AC Immune (ACIU) Expected to Beat Earnings Estimates: Should You Buy?AC Immune (ACIU) Expected to Beat Earnings Estimates: Should You Buy?
finance.yahoo.com - November 5 at 1:09 PM
AC Immune SA Common Stock (ACIU) Advanced ChartingAC Immune SA Common Stock (ACIU) Advanced Charting
www.nasdaq.com - October 28 at 7:19 PM
AC Immune SA Common Stock (ACIU) Real-Time QuotesAC Immune SA Common Stock (ACIU) Real-Time Quotes
www.nasdaq.com - October 28 at 2:19 PM
AC Immune to Host Key Opinion Leader Event: Untangling Tau Pathology to Treat Alzheimers and Neurodegenerative DiseasesAC Immune to Host Key Opinion Leader Event: 'Untangling' Tau Pathology to Treat Alzheimer's and Neurodegenerative Diseases
www.marketwatch.com - October 24 at 8:04 AM
AC Immune to Host Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative DiseasesAC Immune to Host Key Opinion Leader Event: ‘Untangling’ Tau Pathology to Treat Alzheimer’s and Neurodegenerative Diseases
finance.yahoo.com - October 24 at 8:04 AM
Good news on Biogens aducanumab stokes AC Immune, up 18% premarketGood news on Biogen's aducanumab stokes AC Immune, up 18% premarket
seekingalpha.com - October 22 at 12:59 PM
These Factors Make AC Immune SA (NASDAQ:ACIU) An Interesting InvestmentThese Factors Make AC Immune SA (NASDAQ:ACIU) An Interesting Investment
finance.yahoo.com - September 25 at 4:11 PM
AC Immune to Earn Milestone From Lilly for Alzheimers DrugAC Immune to Earn Milestone From Lilly for Alzheimer's Drug
finance.yahoo.com - September 23 at 3:58 PM
AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer(TM) ProgramAC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer(TM) Program
www.marketwatch.com - September 20 at 12:47 PM
AC Immune earns CHF30M milestone from Eli LillyAC Immune earns CHF30M milestone from Eli Lilly
seekingalpha.com - September 20 at 12:47 PM
AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer™ ProgramAC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer™ Program
finance.yahoo.com - September 20 at 12:47 PM
6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day6 Small Drug Stocks in Focus Ahead of World Alzheimer's Day
finance.yahoo.com - September 20 at 12:47 PM
AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620
finance.yahoo.com - September 17 at 11:17 AM
AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinsons Disease Diagnostic Imaging AgentAC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson's Disease Diagnostic Imaging Agent
www.marketwatch.com - September 4 at 12:05 PM
AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging AgentAC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent
finance.yahoo.com - September 4 at 12:05 PM
Is AC Immune (NASDAQ:ACIU) Using Too Much Debt?Is AC Immune (NASDAQ:ACIU) Using Too Much Debt?
finance.yahoo.com - August 19 at 6:09 PM
AC Immune up 10% premarket on Q2 resultsAC Immune up 10% premarket on Q2 results
seekingalpha.com - August 14 at 6:00 PM
AC Immune Reports Q2 2019 Financial Results, Business and Clinical UpdateAC Immune Reports Q2 2019 Financial Results, Business and Clinical Update
finance.yahoo.com - August 14 at 9:01 AM
AC Immune collaborates with University of Pennsylvania for TDP-43 in neurodegenerative diseasesAC Immune collaborates with University of Pennsylvania for TDP-43 in neurodegenerative diseases
seekingalpha.com - August 12 at 9:21 AM
AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative DiseasesAC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases
finance.yahoo.com - August 12 at 9:21 AM
Analysts Estimate AC Immune (ACIU) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate AC Immune (ACIU) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - August 7 at 5:21 PM
AC Immune launches study of Alzheimers candidate; shares up 2%AC Immune launches study of Alzheimer's candidate; shares up 2%
seekingalpha.com - August 1 at 11:21 AM
AC Immune Initiates Phase I Study for Alzheimers DiseaseAC Immune Initiates Phase I Study for Alzheimer's Disease
finance.yahoo.com - July 18 at 5:26 PM
AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer(TM), an Investigational Treatment for Alzheimers DiseaseAC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer(TM), an Investigational Treatment for Alzheimer's Disease
www.marketwatch.com - July 17 at 10:00 AM
AC Immune launches early-stage ACI-3024 study for Alzheimer’s DiseaseAC Immune launches early-stage ACI-3024 study for Alzheimer’s Disease
seekingalpha.com - July 17 at 10:00 AM
AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down SyndromeAC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down Syndrome
finance.yahoo.com - July 11 at 9:31 AM
This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel